ADA asks FDA to maintain rule regulating premium cigars
July 30, 2018
Silver Spring, Md
. — The ADA has signed onto a letter asking the U.S. Food and Drug Administration to not reconsider its decision to regulate premium cigars.
Along with more than 40 other public health groups, including the American Academy of Pediatrics and the American Association of Dental Research, the ADA filed the comments, sent July 25 to the FDA, in response to a proposal to exempt premium cigars from its oversight as part of a final rule issued in 2016.
The rule, which last year the FDA announced it would delay enforcing until 2021
, would require tobacco manufacturers to receive FDA approval before marketing premium cigars and e-cigarettes, depending on when those products were introduced.
The letter from the ADA and other public health groups includes summaries and references to cigar-related research since 2016, stating "cigar smokers have an elevated risk of disease and mortality than never smokers. …All cigars, including large cigars (some of which are premium cigars) deliver significant amounts of toxins an nicotine."
The letter says that studies and data that have emerged since the final rule was issued "in no way undercut the FDA's well-reasoned decision against a premium cigar exemption; indeed, they strengthen the scientific support for regulating all cigars."
The ADA supports public policies to prevent tobacco use and urges its members to become fully informed about tobacco use prevention and cessation. The Association also aims to continue to educate and inform membership and the public about the health hazards attributed to the use of both traditional and nontraditional tobacco products, according to House of Delegates Resolution 78H-2016.
For more information on the ADA's advocacy efforts on tobacco visit ADA.org/tobacco